JENNA MATTHEWS: Open Payments
NPI 1689210924 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,636 in 74 payments from 20 companies in 2025. Trend: 2023 $998 · 2024 $1,284 · 2025 $1,636
Food & beverage: $1,636
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $269 |
| Travere Therapeutics, Inc. | 9 | $234 |
| Otsuka America Pharmaceutical, Inc. | 10 | $177 |
| Novo Nordisk Inc | 5 | $103 |
| Vantive US Healthcare LLC | 2 | $101 |
| ANI Pharmaceuticals, Inc. | 4 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $71 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
| Calliditas Therapeutics US Inc. | 2 | $67 |
| Ardelyx, Inc. | 2 | $62 |
Products named: KRYSTEXXA, JYNARQUE, PURIFIED CORTROPHIN GEL, Ozempic, TAVNEOS, Kerendia, FARXIGA, TARPEYO.
Industry payments across MO — which companies pay providers there.
